CAR-T Warning for Secondary Malignancies: Warranted or Not?

(MedPage Today) -- Early in 2024, we reported on the FDA's call for new boxed warnings on the labeling of all approved chimeric antigen receptor (CAR) T-cell therapies for the potential risk for secondary T-cell malignancies. In this report, we...